Quote | 9 Meters Biopharma Inc. (NASDAQ:NMTR)
Last: | $0.0722 |
---|---|
Change Percent: | 12.88% |
Open: | $0.1103 |
Close: | $0.0722 |
High: | $0.1127 |
Low: | $0.0715 |
Volume: | 5,278,566 |
Last Trade Date Time: | 07/25/2023 03:00:00 am |
News | 9 Meters Biopharma Inc. (NASDAQ:NMTR)
RALEIGH, NC / ACCESSWIRE / May 30, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced that the Board of Directors has accepted the resignation of John Temperato as President ...
2023-05-15 17:40:12 ET 9 Meters Biopharma press release ( NASDAQ: NMTR ): Q1 GAAP EPS of -$1.02 misses by $0.24 . As of March 31, 2022, the Company's unrestricted cash and cash equivalents totaled approximately $6.9 million, compared to approximately $12.6 million as o...
Message Board Posts | 9 Meters Biopharma Inc. (NASDAQ:NMTR)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $NMTR 21% v1,2M C2.39 f12,955M H2.72 fwas203M in 2021-0129 | znewcar1 | investorshangout | 01/06/2023 5:46:34 AM |
$2.40 nice | wesley_ | investorshub | 01/05/2023 10:50:27 PM |
$5 PRICE TARGET RELEASED YESTERDAY OUTPERFORM $$$$$$ | 1hot toddy | investorshub | 09/28/2022 3:24:14 PM |
It's nice to see behind the curtain.....lol | Zardiw | investorshub | 06/25/2022 12:02:00 AM |
was that mean front load? thanks it caught | jablome | investorshub | 06/24/2022 7:22:15 PM |
News, Short Squeeze, Breakout and More Instantly...
9 Meters Biopharma Inc. Company Name:
NMTR Stock Symbol:
NASDAQ Market:
RALEIGH, NC / ACCESSWIRE / May 30, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced that the Board of Directors has accepted the resignation of John Temperato as President ...
RALEIGH, NC / ACCESSWIRE / May 15, 2023 / 9 Meters Biopharma, Inc. (Nasdaq:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today provided a business update and announced financial results for the first quarter ended March 31, 2...
RALEIGH, NC / ACCESSWIRE / April 5, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced receipt of a written response from the U.S. Food and Drug Administration (FDA) on the r...